3 unknown. 3 Phase 3, 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 3 | Unknown 3 |
| Phase 2 | 2 | Unknown 2 |
Follow SOC: new trials by email Literature Review of SOC trials Research Report on SOC
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Clinical Study for the Efficacy and Safety of Ropeginterferon Alfa-2b in Adult COVID-19 Patients With Comorbidities Ropeginterferon alfa-2b, SOC - COVID-19 | Phase 2 / Phase 3 | Unknown | National Taiwan University Hospital | 60 | 2023-05-15 | 2023-04-11 |
| Study to Evaluate Efficacy and Safety of Switching to VM-1500A-LAI + 2NRTIs From the 1st Line Standard of Care Therapy VM-1500A-LAI, Standard of Care - HIV-1-infection | Phase 2 / Phase 3 | Unknown | Viriom | 438 | 2022-04-01 | 2022-01-24 |
| The Impact of Fecal Microbiota Transplantation as an Immunomodulation on the Risk Reduction of COVID-19 Disease Progression With Escalating Cytokine Storm and Inflammatory Parameters Human fecal microbiota, MBiotix HBI, Placebo, SOC - Covid19 | Phase 3 | Unknown | Medical University of Warsaw | 366 | 2021-04-01 | 2021-04-01 |
COVID-19 (2)
Medical University of Warsaw (1) · National Taiwan University Hospital (1) · Viriom (1)
Russia (1) · Taiwan (1)
Anastasia Pokrovskaya, PhD (1) · Wang-Huei Sheng, M.D. Ph.D (1)